Get started
Author

Bilal Bashir

Observed names: B. Bashir, BILAL BASHIR, Bashir B, Bashir, Bilal
Observed institutions: Lancashire Teaching Hospitals NHS Foundation Trust, Edge Hill University, University Hospitals of Morecambe Bay NHS Foundation Trust, Lady Reading Hospital, Salford Royal NHS Foundation Trust, Manchester Royal Infirmary, Wrightington, Wigan and Leigh NHS Foundation Trust, Bolton NHS Foundation Trust, University of Manchester, University of Kurdistan Hewler, National Institute for Health and Care Research, Manchester University NHS Foundation Trust, Wrightington Hospital, Salford Royal Hospital, Health Education North West, The Christie Hospital, The Christie NHS Foundation Trust, Royal Bolton Hospital, NIHR Manchester Clinical Research Facility, East Lancashire Hospitals NHS Trust, Wellcome Trust
ORCID: 0000-0003-3733-8331
Observed ORCID: 0000-0003-3733-8331
OpenAlex ID: A5044475813
Paraoxonase 1 and atherosclerosis
2023 · Paul N. Durrington, Bilal Bashir, et al. · Frontiers in Cardiovascular Medicine · 73
PDF
Lipids and peripheral neuropathy
2021 · Zohaib Iqbal, Bilal Bashir, et al. · Current Opinion in Lipidology · 72
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy
2021 · Ioannis N. Petropoulos, Georgios Ponirakis, et al. · Clinical Therapeutics · 69
PDF
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options
2023 · Bilal Bashir, Jan H. Ho, et al. · Metabolites · 44
PDF
Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia
2024 · Bilal Bashir, Jonathan Schofield, et al. · Frontiers in Cardiovascular Medicine · 40
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
2026 · Scott B. Vafai, Jörg Täubel, et al. · New England Journal of Medicine · 39
PDF
Non-diabetic ketoacidosis: a case series and literature review
2020 · Bilal Bashir, Ahmed A Fahmy, et al. · Postgraduate Medical Journal · 29
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry
2024 · Bilal Bashir, Paul Downie, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 25
Microvascular complications of obesity and diabetes—Role of bariatric surgery
2023 · Bilal Bashir, Zohaib Iqbal, et al. · Obesity Reviews · 25
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)
2024 · Bilal Bashir, See Kwok, et al. · Atherosclerosis · 20
PDF
Lipids, Lipid-Lowering Therapy, and Neuropathy: A Narrative Review
2022 · Raabya Pasha, Shazli Azmi, et al. · Clinical Therapeutics · 18
Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia
2024 · Bilal Bashir, Maryam Ferdousi, et al. · Current Opinion in Lipidology · 14
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
2025 · Paul N. Durrington, Bilal Bashir, et al. · Antioxidants · 13
PDF
Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular risk
2022 · Zohaib Iqbal, Bilal Bashir, et al. · Atherosclerosis · 13
Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes
2022 · Bushra Hassan Marouf, Zohaib Iqbal, et al. · Clinical Therapeutics · 12
Small nerve fibre damage and cardiac autonomic dysfunction in patients with hypertriglyceridaemia
2025 · Bilal Bashir, Raabya Pasha, et al. · Atherosclerosis · 8
Impact of Lipid-lowering Therapy on Cancer Risk: A Narrative Review
2024 · Raabya Pasha, Bilal Bashir, et al. · Clinical Therapeutics · 7
Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery
2023 · Bilal Bashir, Safwaan Adam, et al. · Current Opinion in Lipidology · 7
Lipoprotein (a) in familial hypercholesterolaemia
2022 · Paul N. Durrington, Bilal Bashir, et al. · Current Opinion in Lipidology · 6
Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study
2025 · Raabya Pasha, Anoushka Kamath, et al. · Diabetes Obesity and Metabolism · 5
Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care – Real World Multicentre Experience
2022 · Bilal Bashir, Shonagh Haslam, et al. · Cureus · 5
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom
2025 · Bilal Bashir, Natalie Forrester, et al. · Genetics in Medicine Open · 4
Neurodegeneration in familial chylomicronemia syndrome
2025 · Bilal Bashir, Raabya Pasha, et al. · Journal of clinical lipidology · 3
The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study
2024 · Adrian Heald, Fahmida Mannan, et al. · Diabetes Therapy · 3
PDF
The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence
2021 · Safwaan Adam, Jan Hoong Ho, et al. · Current Opinion in Lipidology · 3
Works count: 73
Citation count: 567
H-index: 13
I10-index: 15
Year
Topic
Type